Related Experiment Video
Updated: Oct 5, 2025
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
689
Nutraceuticals use and type 2 diabetes mellitus
Ying Le1, Bingsen Wang2, Meng Xue1
1Department of Endocrinology and Metabolism, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong, China.
Current Opinion in Pharmacology
|January 23, 2022
Summary
Nutraceuticals show promise for managing type 2 diabetes mellitus (T2DM). This review explores popular nutraceuticals, their effects, and mechanisms for T2DM prevention and glycemic control.
Area of Science:
- Metabolic disease research
- Nutritional science
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) is a major global health concern.
- Developing T2DM treatments with fewer side effects is a priority.
- Nutraceuticals are increasingly recognized for T2DM prevention and management.
Purpose of the Study:
- To review popular nutraceuticals for T2DM.
- To examine the effects of nutraceuticals on T2DM.
- To explore the mechanisms of action for glycemic control.
Main Methods:
- Literature review of scientific studies.
- Analysis of nutraceuticals including probiotics, prebiotics, Vitamin D, n-3 fatty acids, and plant-derived compounds.
- Evaluation of evidence for T2DM prevention and glycemic control.
Main Results:
- Specific nutraceuticals demonstrate potential in T2DM management.
- Mechanisms involve various pathways influencing glucose metabolism.
- Evidence supports roles in both prevention and glycemic control.
Conclusions:
- Nutraceuticals offer a promising complementary approach to T2DM care.
- Further research into specific nutraceutical mechanisms is warranted.
- Personalized nutritional strategies may enhance T2DM treatment outcomes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
01:15Diabetes: Management and Pharmacotherapy
428
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
428
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
328
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
328
01:36Carbohydrate Metabolism
12.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.3K
01:17Oral Hypoglycemic Agents: Sulfonylureas
381
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
381
01:22Diabetes Mellitus: Overview and Type I Subtype
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K